Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Cancer Symptom Trials (CST)
Cancer Symptom Trials (CST)
by SoulfulDreamer
Membership. Overview. Applications are welcome fro...
Cancer Trials 30 years in the making
Cancer Trials 30 years in the making
by dorothy
Professor John . Simes. Director, NHMRC Clinical T...
Canadian Cancer Trials Group
Canadian Cancer Trials Group
by violet
“Who We Are & Where We Are Going”. 2022 Ne...
Demystifying Clinical Trials: Focusing on Trials with Therapeutic Intent
Demystifying Clinical Trials: Focusing on Trials with Therapeutic Intent
by tabitha
Ashley E. Ross MD PhD. Executive Medical Director....
Lesson 3: Clinical Trials
Lesson 3: Clinical Trials
by margaret
Module 3: The Basics of Health Care. Oncology Pati...
Mantle Cell Lymphoma Clinical TrialsThe following clinical trials are
Mantle Cell Lymphoma Clinical TrialsThe following clinical trials are
by byrne
617TRIALS FOR RELAPSED/REFRACTORY PATIENTS19-021p ...
Building a Cancer Center Clinical Trial Portfolio with Indu
Building a Cancer Center Clinical Trial Portfolio with Indu
by alexa-scheidler
Essential . and Virtuous Aspiration or . Mentorin...
Global reach for Australian trials
Global reach for Australian trials
by sadie
Anna Nowak. MBBS FRACP PhD. Chair, . CoOperative. ...
Return on investment of clinical trials
Return on investment of clinical trials
by bethany
Associate Professor Rachael Morton. Director of He...
Researched and
Researched and
by gagnon
Authored by Prof Michael C Herbst [D Litt et Phil ...
Biomarkers in Phase II designs in cancer clinical trials
Biomarkers in Phase II designs in cancer clinical trials
by conchita-marotz
Methods in Clinical Cancer Research. February 12,...
DATA DRIVEN TRIALS FOR
DATA DRIVEN TRIALS FOR
by phoebe-click
ONCOLOGY STUDIES. Prasida Dinesh. Associate Direc...
Part in Cancer Treatment Research StudiesUS Department of Health Huma
Part in Cancer Treatment Research StudiesUS Department of Health Huma
by cora
Taking 1-800-4-CANCER 1-800-422-6237Taking Part in...
Ann O’Mara, PhD, RN, FAAN
Ann O’Mara, PhD, RN, FAAN
by udeline
Head, Palliative Care Research. Division of Cancer...
www.thelancet.com Published online Feb 7, 2019
www.thelancet.com Published online Feb 7, 2019
by phoebe
Increasing the dose intensity of chemotherapy by m...
End-points utilized in breast cancer
End-points utilized in breast cancer
by evelyn
clinical . trials - Discussion. Novartis Oncology...
Cancer and Hematology Clinical Research Program
Cancer and Hematology Clinical Research Program
by CantTouchThis
a. nd Translational Research Core. About the CHCRP...
Cancer Prevention Clinical Trials at
Cancer Prevention Clinical Trials at
by lindy-dunigan
[Name of Clinical Site]. First and Last Name of P...
Metastatic Breast Cancer: A Medical Update
Metastatic Breast Cancer: A Medical Update
by liane-varnes
Jennifer M. Matro, MD. Rena Rowan Breast Center. ...
Putnam County Hospital CANCER CENTER
Putnam County Hospital CANCER CENTER
by calandra-battersby
2016. The Cancer Center is located on the 2. nd....
Cancer Center March 30,
Cancer Center March 30,
by celsa-spraggs
2015. Houston Methodist . Vision. Houston Methodi...
NCI Division of Cancer Prevention
NCI Division of Cancer Prevention
by celsa-spraggs
NCI Division of Cancer Prevention Ongoing Activi...
Course Proposal: Methods in Clinical Cancer Research
Course Proposal: Methods in Clinical Cancer Research
by white
. Primary Instructor: . Elizabeth Garrett-Mayer, P...
Disparities in Prostate Cancer Outcomes: Race, Access, and Ancestry
Disparities in Prostate Cancer Outcomes: Race, Access, and Ancestry
by Soulmate
Andrew J Armstrong MD . ScM. FACP. National Allia...
Cancer Prostate November, 2015
Cancer Prostate November, 2015
by BraveButterfly
1. Global Burden of Disease Cancer Collaboration, ...
Dr Verna Lavender Senior Lecturer in Cancer Care Oxford Brookes University
Dr Verna Lavender Senior Lecturer in Cancer Care Oxford Brookes University
by patricia
Cancer Nurse Researcher Oxford University Hospital...
The Research Question Flexible sigmoidoscopy (FS) is the only cancer screening modality (for any ty
The Research Question Flexible sigmoidoscopy (FS) is the only cancer screening modality (for any ty
by isla
Is this unique outcome more attributable to preven...
UCSF 9 th Annual Gyn Cancer Symposium
UCSF 9 th Annual Gyn Cancer Symposium
by lucy
Clinical Trials: What to expect on a clinical tria...
Clinical Trial Protocol & Amendments
Clinical Trial Protocol & Amendments
by liane-varnes
William Petros, PharmD, FCCP. Professor, Schools ...
The Westmead and MIA
The Westmead and MIA
by myesha-ticknor
Phase I experience. Matteo Carlino. Crown Princes...
Research on the Medicinal Uses of Cannabis
Research on the Medicinal Uses of Cannabis
by briana-ranney
Presented by: Candice Beathard, PhD. December 15,...
Rahn Kennedy Bailey, M.D., D.F.A.P.A.
Rahn Kennedy Bailey, M.D., D.F.A.P.A.
by jane-oiler
Executive Director Behavioral Medicine. Chair o...
Balancing the practical implications of adaptive designs with the statistical benefits
Balancing the practical implications of adaptive designs with the statistical benefits
by stefany-barnette
Mahesh Parmar. MRC . Clinical Trials Unit at . UC...
NCI Experimental Therapeutics Clinical Trials Network
NCI Experimental Therapeutics Clinical Trials Network
by tawny-fly
(ETCTN). Central IRB Education Day. 28 April 2015...
End-points utilized in
End-points utilized in
by marina-yarberry
End-points utilized in breast cancer clinical ...
Clinical Trials: What you need to know to study diet and nutritional variables
Clinical Trials: What you need to know to study diet and nutritional variables
by startse
(emphasis on fruits and vegetables and their compo...
Key Findings and ImplicationsTHE EVOLUTION OF BIOMARKER USE IN CLINICA
Key Findings and ImplicationsTHE EVOLUTION OF BIOMARKER USE IN CLINICA
by murphy
2 Understanding the biomarker research activity, i...
1 Lecture3 Experiment, trial and survey
1 Lecture3 Experiment, trial and survey
by freya
Collecting data. 2. Data . Statistics is a way of ...
Design considerations for drug development in the era of immuno-oncology
Design considerations for drug development in the era of immuno-oncology
by isabella
Elizabeth Garrett-Mayer, PhD. Director, Division o...
Oncology Clinical Trials
Oncology Clinical Trials
by holly
Sylvia . O’Neill, . MD . Executive Di...